European stock indices edge lower, led by U.K. shares amid disappointing earnings reports and accelerating consumer price growth. Fund manager pressure mounts on the board of Britain’s No. 2 drugs maker AstraZeneca to entertain a thrice-sweetened $117 billion bid from pharmaceuticals giant Pfizer following a statement from Schroders, while FTSE 100 stalwarts Vodafone Group, the telecom, and variety-store retailer Marks & Spencer both decline after reporting full-year earnings figures. Vodafone says investment will rein in profit in the current year and Marks & Spencer fails to wow shareholders with upbeat commentary on the margin outlook.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
